Publicacións nas que colabora con María Moure González (11)

2024

  1. Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network

    Cardiovascular Diabetology, Vol. 23, Núm. 1

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

2019

  1. Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry

    Journal of the American Heart Association, Vol. 8, Núm. 3

2018

  1. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835

2017

  1. Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure

    International Journal of Cardiology, Vol. 230, pp. 108-114

2016

  1. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists

    British Journal of Haematology, Vol. 174, Núm. 4, pp. 610-623

2012

  1. Evidence for a role of advanced glycation end products in atrial fibrillation

    International Journal of Cardiology, Vol. 157, Núm. 3, pp. 397-402

2011

  1. Manual de diagnóstico y tratamiento de insuficiencia cardíaca crónica

    Santiago de Compostela: Complexo Hospitalario Universitario de Santiago de Compostela, 2011

  2. Productos de glicación avanzada: nuevo marcador de disfunción renal en pacientes con insuficiencia cardíaca crónica

    Medicina Clinica, Vol. 136, Núm. 12, pp. 513-521

  3. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of seattle heart failure score

    American Journal of Cardiology, Vol. 107, Núm. 6, pp. 938-944

2010

  1. Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels

    European Journal of Heart Failure, Vol. 12, Núm. 10, pp. 1092-1100